NCT03739632 Study to Explore the Effective Doses and to Assess the Safety and Efficacy of Hypidone Hydrochloride Tablets Status COMPLETED Phase PHASE2
NCT03739203 The Objective of This Study is to Evaluate the Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone Status COMPLETED Phase PHASE3
NCT03738215 Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone Status COMPLETED Phase PHASE3
NCT03737474 A Long-Term Study of Brexpiprazole in Patients With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT03735576 Cognitive Behavioural Therapy for the Treatment of Late Life Depression Status COMPLETED Phase NA
NCT03726658 Zelquistinel in the Treatment of Adults With Major Depressive Disorder Status COMPLETED Phase PHASE1/PHASE2
NCT03722095 Research on the Effects of Combined Neurostimulation Protocols on Stress Status COMPLETED Phase NA
NCT03718013 Efficacy and Safety of Accelerated Transcranial Magnetic Stimulation With H1-coil (dTMS) Status COMPLETED Phase NA
NCT03716869 Universal vs. Targeted School Screening for Adolescent Major Depressive Disorder Status COMPLETED Phase NA
NCT03711123 Group Metacognitive Therapy vs Clinical Management for Depression Status UNKNOWN Phase NA
NCT03711045 An Eye Tracking Study of Affective Disorder Patients With Suicide Risk Status UNKNOWN Phase N/A
NCT03703414 Characterization of Microbial, Immune and Epigenetic Biomarkers for Major Depressive Disorder and ECT Treatment Status UNKNOWN Phase N/A
NCT03697603 A Study of Brexpiprazole in Patients With Major Depressive Disorder Status COMPLETED Phase PHASE2/PHASE3
NCT03693105 The Effects of SAINT® Neuromodulation System on Explicit and Implicit Suicidal Cognition Status TERMINATED Phase PHASE2/PHASE3